Intuitive Surgical (NASDAQ:ISRG) Earns Neutral Rating from Analysts at CICC Research

Analysts at CICC Research began coverage on shares of Intuitive Surgical (NASDAQ:ISRG - Get Free Report) in a research report issued on Monday. The brokerage set a "neutral" rating and a $550.00 price target on the medical equipment provider's stock. CICC Research's price target indicates a potential downside of 4.09% from the company's current price.

Other equities analysts also recently issued research reports about the stock. Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday. Mizuho lifted their price target on shares of Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. Oppenheimer reiterated a "market perform" rating on shares of Intuitive Surgical in a research note on Friday, October 18th. Citigroup lifted their target price on Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research note on Friday. Finally, UBS Group raised their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and an average target price of $613.10.

Intuitive Surgical Trading Down 1.8 %

NASDAQ ISRG traded down $10.57 on Monday, hitting $573.48. 2,439,723 shares of the stock traded hands, compared to its average volume of 2,025,429. The company has a market capitalization of $204.26 billion, a P/E ratio of 92.20, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The stock has a 50-day moving average of $547.16 and a 200 day moving average of $505.21. Intuitive Surgical has a twelve month low of $364.17 and a twelve month high of $616.00.

Insider Activity at Intuitive Surgical

In related news, insider Jamie Samath sold 269 shares of the firm's stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total transaction of $145,230.41. Following the completion of the transaction, the insider now owns 8,757 shares of the company's stock, valued at $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 376 shares of the business's stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total transaction of $202,664.00. Following the completion of the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 42,453 shares of company stock worth $22,059,506 over the last quarter. 0.90% of the stock is currently owned by company insiders.

Institutional Trading of Intuitive Surgical

Large investors have recently added to or reduced their stakes in the business. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical during the 4th quarter valued at $26,000. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical in the 3rd quarter valued at $33,000. Decker Retirement Planning Inc. purchased a new position in Intuitive Surgical in the 4th quarter worth about $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical during the 3rd quarter worth about $38,000. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.